Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Trehalose as add-on Therapy in Bipolar Depression

NCT02800161 is registered in ClinicalTrials.gov with Consorcio Centro de Investigación Biomédica en Red (CIBER) as lead sponsor.

NCT NCT02800161
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02800161 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Trehalose as add-on Therapy in Bipolar Depression
Lead sponsor
Consorcio Centro de Investigación Biomédica en Red (CIBER)
Phase
Phase 3
Overall status
Completed
Start date
June 30, 2016
Completion date
October 31, 2022
Enrollment
60 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bipolar depression, bipolar disorder